Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer
Status:
Terminated
Trial end date:
2018-03-24
Target enrollment:
Participant gender:
Summary
RATIONALE: Nicotine patches may reduce hand-foot syndrome in patients receiving capecitabine
for metastatic breast cancer. It is not yet known which nicotine patch regimen may be more
effective in reducing hand-foot syndrome.
PURPOSE: This randomized clinical trial is studying which schedule of using nicotine patches
is more effective in reducing hand-foot syndrome in patients who are receiving capecitabine
for metastatic breast cancer.